Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Tiltan Pharma enrolls first U.S. patient in phase II TL-118 study

Nov. 14, 2012

Joint effort between Eisai and Epizyme results in new EZH2 inhibitors

Nov. 14, 2012

Sunshine Biopharma begins IND-enabling studies for Adva-27a

Nov. 14, 2012

Researchers divulge new SERMs for the treatment of breast cancer

Nov. 14, 2012

AstraZeneca presents novel PI3K inhibitors

Nov. 14, 2012

Foundation Medicine develops genomic profiling collaborations

Nov. 14, 2012

Vaccibody receives grant to develop therapeutic cervical cancer vaccine

Nov. 14, 2012

Aeterna Zentaris' phase I/II study of AEZS-108 advances

Nov. 14, 2012

China's State Food and Drug Administration approves first-in-human trial of APX-003

Nov. 13, 2012

Phase III pancreatic cancer study of Abraxane meets primary endpoint

Nov. 13, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...